Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Aggregate Index of Systemic Inflammation) in Patients with and without Diabetes or Prediabetes
Agnieszka Tuzimek,Ewelina Dziedzic,Joanna Beck,Wacław Kochman
DOI: https://doi.org/10.2147/jir.s454117
IF: 4.5
2024-04-30
Journal of Inflammation Research
Abstract:Agnieszka Tuzimek, 1 Ewelina A Dziedzic, 1 Joanna Beck, 2, 3 Wac&lstrokaw Kochman 1 1 Cardiovascular Clinic, Centre of Postgraduate Medical Education, Warsaw, 01-813, Poland; 2 Bioimaging Research Center, Institute of Physiology and Pathology of Hearing, Warsaw, 02-042, Poland; 3 Medical Faculty, Lazarski University, Warsaw, 02-662, Poland Correspondence: Ewelina A Dziedzic, Cardiovascular Clinic, Centre of Postgraduate Medical Education, 99/103 Marymoncka St, Warsaw, 01-813, Poland, Email Purpose: Type 2 diabetes mellitus (DM) is a recognized independent risk factor for both chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS). Patients with DM and prediabetes (preDM) face an increased ACS risk. Inflammation plays a significant role in the pathogenesis of both CCS and ACS. This study delves into novel inflammatory markers, such as the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI, also known as SIIRI or PIV), to explore their relationship with ACS and CCS in patients that have been or have not been diagnosed with DM or preDM. Patients and Methods: This study included data of 493 patients with chest pain undergoing coronary angiography. They were categorized into four groups: 1) without DM/preDM and with CCS; 2) with both DM/preDM and CCS; 3) without DM/preDM and with ACS, 4) with both DM/preDM and ACS. Standard methods of statistical analysis were used to reveal possible differences between groups and to find the most influential ACS risk factors in groups with DM/preDM and without DM/preDM. Results: The analysis showed no significant differences in SII, SIRI, or AISI between the respective patient groups. A logistic regression analysis generated a model incorporating SII, high-density lipoprotein, and low-density lipoprotein levels as the influential ACS risk factors for patients with DM/preDM. The model demonstrated 71.0% accuracy, 37.0% sensitivity, and 89.4% specificity. Conclusion: The findings suggest that the aforementioned inflammatory markers may have potential for distinguishing DM/preDM patients at higher risk of ACS at a low financial cost. However, further comprehensive and well-designed research is required to validate their clinical utility. Plain Language Summary: People with type 2 diabetes (DM) and prediabetes (preDM) have a higher risk of heart problems. These include chronic coronary syndrome (CCS) and acute coronary syndrome (ACS). Inflammation is a key element in these issues. We looked at 493 patients with chest pain. We divided them into groups based on diabetes status (DM/preDM vs no diabetes) and heart conditions (ACS and CCS). We explored new markers related to inflammation. These include the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) that all can be calculated from simple blood tests. We found no differences in these markers between groups. To understand ACS risk factors better, we used statistical analysis. The model found key factors for patients with DM/preDM: SII, LDL, and low-density lipoprotein levels. It was accurate (71.0%), but sensitivity was 37.0%, and specificity was 89.4%. These markers could be helpful in identifying DM/preDM patients at risk of ACS with low cost tests. We need more research to confirm their use in real-life medical settings. Keywords: coronary artery disease, ischemic heart disease, atherosclerosis, myocardial infarction, pan-immune-inflammation value, systemic immune-inflammation response index, systemic immune-inflammation index, diabetes Type 2 diabetes mellitus (DM) is an independent risk factor for chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS). 1 Epidemiological data revealed that almost a third of DM patients are concurrently affected with cardiovascular disease, and approximately one in ten suffered from ACS. 2 Inflammation is a pivotal factor in the pathogenesis of both DM and atherosclerosis, one of the underlying causes of CCS. 3 Inflammatory processes influence various mechanisms involved in atherosclerotic plaque formation and rupture, ultimately culminating in the onset of ACS. 4 Recently, the degree of inflammation has been characterized in terms of the ratios of various leukocyte subtypes in the complete blood count: the systemic immune-inflammation index (SII) the systemic inflammation response index (SIRI), and the aggregate index of systemic inflammation (AISI), which is also referred to as systemic immune-inflammation response index (SIIRI) or -Abstract Truncated-
immunology